HealthTronics bids for EndoCare
This article was originally published in The Gray Sheet
Executive Summary
In a letter to Endocare's board of directors, released after the markets closed on Aug. 6, HealthTronics says it wants to buy the cryosurgery device company for $2.28 per share, about a 20% premium over Endocare's Aug. 6 closing stock price. Endocare responds that its board will review the unsolicited bid and consult with advisers. Both companies have a focus on prostate cancer. In second-quarter earnings released Aug. 6, Endocare's sales were flat at $7.9 million
You may also be interested in...
Endocare rejects acquisition bid
Cryocare prostate cancer cryoablation device developer Endocare rejects HealthTronics' unsolicited acquisition proposal, the company announces Aug. 13. HealthTronics, a urology service provider and device distributor, offered to pay $2.28 per share Aug. 6, but Endocare's board unanimously agreed the offer is inadequate (1"The Gray Sheet" Aug. 11, 2008, In Brief)
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.